News
Celgene has announced that it has chosen not to scoop up Sutro Biopharma, rejecting to take advantage of an option outlined in its $1 billion...
A team of researchers have revealed the promising results of a trial evaluating a potential treatment for Niemann-Pick type C (NPC), a rare...
Paul Workman, Chief Executive and President of the Institute of Cancer Research, examines the spiralling cost of cancer treatments and what can be...
Largest biotech investment ever, a drug to stop type 1 diabetes progression, and proof that women have more active brains. Check out our top 10 most...
Great news in the cardiovascular space as results from the National Heart Failure Audit indicate that better treatment has led to hundreds of lives...
In possibly the biggest single biotech investment ever made, Swiss biotech firm Roivant has received a $1.1 billion cash injection thanks to an...
NICE has announced that it has given final appraisal recommending Bayer’s Nexavar (sorafenib) for the treatment of advanced hepatocellular...
In the first large-scale study of its kind, a team of researchers at Boston Medical Center’s Grayken Center for Addiction Medicine has discovered...
Cancer Research UK (CRUK) has announced a collaboration with Biotecnol to develop an experimental treatment for advanced solid tumours
In a first for the disease area, an immunotherapy treatment for diabetes has proven its ability to halt the progression of the type 1 form of the...
